Answers are grounded in this paper and cite their sources.
Lung transplantation (LTx) is regarded as an effective treatment of end-stage lung disease, yet recipients are at significant risk of developing Bronchiolitis Obliterans Syndrome (BOS). Previous studies have shown that BOS is related to ventilatory heterogeneity, IL-8 and airway hyper-responsiveness (AHR). What has been less explored is the potential for these measures taken early post-LTx to predict future BOS or death. Methods: ) ventilation heterogeneity from the multiple breath nitrogen washout (MBNW) at regular intervals over a 12month period. AHR was also measured within 6 months of LTx and IL-8 was estimated from bronchoalveolar lavage taken at the time of pulmonary function measures. Patients were further monitored for BOS or death during a 10-year follow-up period. Results: /mL was not predictive of BOS/Death. Conclusion: or IL-8 within 6-month post LTx is associated with greatly increased risk of BOS according to the 2001 definition or death within 10 years. Restrictive Allograft Syndrome cannot not be fully excluded due to the absence of routine static lung volume measurements.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: